secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001178913-25-000259
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion Therapeutics secures ~$3.3M via warrant exercise inducement, issues new warrants
--------------------------------------------------------------------------------

- Holders exercise 2,221,523 existing warrants at $1.35 per share; new warrants issued for same number at $1.50.
- Gross proceeds ~$3.3M; closing expected Jan 30, 2025; net proceeds for general corporate purposes.
- Placement agent H.C. Wainwright receives 7.0% cash fee and 1.0% management fee; also receives placement agent warrants.
- New warrants exercisable for 24 months from registration statement effective date; cashless exercise feature.
- Company agrees not to issue shares or file registration statements until March 18, 2025; no Variable Rate Transactions for one year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325000259/0001178913-25-000259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325000259/zk2532621.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-000259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer